Recursion Pharmaceuticals Inc vs Vertiv Holdings Co — how do they compare? Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B), while Vertiv Holdings Co trades at $305.56 (market cap $112.03B). The key difference: Vertiv Holdings Co is far larger — about 73.2× Recursion Pharmaceuticals Inc's market cap, and Vertiv Holdings Co pays a 0.09% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | VRT | |
|---|---|---|
Market Cap | $1.53B | $112.03B |
Sector | Health | Technology |
52-Week High | $6.79 | $376.23 |
52-Week Low | $2.84 | $121.82 |
Enterprise Value | $946.50M | $112.80B |
Dividend Yield | — | 0.09% |
Trailing returns across standard periods
Latest headlines on both assets
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →